DAVID SMITH: Open Payments
NPI 1821036161 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 105 payments from 19 companies in 2025. Trend: 2023 $1,810 · 2024 $2,042 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $336 |
| Insmed, Inc. | 9 | $248 |
| GENZYME CORPORATION | 11 | $227 |
| Viatris Specialty LLC | 7 | $173 |
| AstraZeneca Pharmaceuticals LP | 10 | $172 |
| Mallinckrodt Hospital Products Inc. | 5 | $149 |
| ANI Pharmaceuticals, Inc. | 6 | $148 |
| Regeneron Healthcare Solutions, Inc. | 11 | $146 |
| United Therapeutics Corporation | 4 | $107 |
| Verona Pharma, Inc. | 4 | $71 |
Products named: DUPIXENT, Arikayce, NUCALA, YUPELRI, ACTHAR, PURIFIED CORTROPHIN GEL, TRELEGY ELLIPTA, Tyvaso.
Industry payments across VA — which companies pay providers there.
